NASOPHARYNGITIS is the #13 most commonly reported adverse reaction for ADRENALINUM, manufactured by ARS Pharmaceuticals Operations, Inc.. There are 1,597 FDA adverse event reports linking ADRENALINUM to NASOPHARYNGITIS. This represents approximately 1.6% of all 96,806 adverse event reports for this drug.
Patients taking ADRENALINUM who experience nasopharyngitis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
NASOPHARYNGITIS1,597 of 96,806 reports
NASOPHARYNGITIS is a less commonly reported adverse event for ADRENALINUM, but still significant enough to appear in the safety profile.
Other Side Effects of ADRENALINUM
In addition to nasopharyngitis, the following adverse reactions have been reported for ADRENALINUM:
NASOPHARYNGITIS has been reported as an adverse event in 1,597 FDA reports for ADRENALINUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is NASOPHARYNGITIS with ADRENALINUM?
NASOPHARYNGITIS accounts for approximately 1.6% of all adverse event reports for ADRENALINUM, making it a notable side effect.
What should I do if I experience NASOPHARYNGITIS while taking ADRENALINUM?
If you experience nasopharyngitis while taking ADRENALINUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.